Recently, Beclin 1 has been identified as a reliable biomarker in monitoring the prognosis for several tumors, such as brain, liver, gastric, colorectal, nasopharyngeal cancers and NK/T cell lymphoma [22], [23], [24], [25], [26]. Here, BECN1 is linked to nasopharyngeal carcinoma.